Analyst commentary on July 25, 2026, impacted the stock valuation involving Burford Capital and Deutsche Bank.
1 report, 1 independent
Updated Jul 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analyst commentary on July 25, 2026, impacted the stock valuation involving Burford Capital and Deutsche Bank.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Analyst rating changes and institutional flows are currently impacting the market sentiment for Burford Capital.Sub-event
Analyst commentary impacts stock valuation involving Burford Capital and Deutsche Bank.1 source
Keep exploring
The entities involved
-
Burford Capital
finance and professional services company
-
Deutsche Bank
German global banking and financial services company
Related events
- Analyst targets are being revised to reflect market concerns regarding future earnings and fuel cost volatility for companies including Goldman Sachs, Carnival Corp., and Deutsche Bank.
- Spyre Therapeutics, Inc. was listed on Nasdaq and received analyst ratings from firms including Deutsche Bank and Stifel.
- Both HSBC and Deutsche Bank provided market analysis and commentary on September 1, 2026.
- Deutsche Bank upgraded Dunelm stock based on strategic upside.
Coverage
Newest first; wire copies grouped- yahoo.comBurford Capital (BUR) Stock Gets Fair Value Bump As Analysts Split On Targets